NDC 16571-862
bupropion hydrochloride 150 mg tablet, extended release
On the label: Rising Pharma Holdings, Inc..
Where it's made
| Factory | Where | Role | Last FDA inspection |
|---|---|---|---|
| Graviti Pharmaceuticals Private Limited | Sangareddy, India | Makes it and tests it | Problems found, fixed voluntarilyJul 28, 2026 · 2 inspections |
Recalls
- Dec 29, 2023 · Class II · Rising Pharma Holding, Inc.
Presence of Foreign Tablets/Capsules
Lots: Lot #: BPA123098A, Exp. Date 06/2025
Class I recalls are the most serious; Class III the least. A recall covers specific lots, listed on each recall.
Product details
- Generic drug
- Bupropion: every company that makes it
- Form
- tablet, extended release, oral
- Strength
- 150 mg
- Approval
- ANDA ANDA211020
- On the market since
- Aug 1, 2022
- Package NDCs
16571-862-0316571-862-0916571-862-1016571-862-1216571-862-50- Official label
- DailyMed (National Library of Medicine), updated Apr 30, 2026
Got it by mail or from a pharmacy you don't know? Look the pharmacy up on Who Filled My Rx?